Company Filing History:
Years Active: 2019
Title: Innovations of Yunpeng Su in Uric Acid Transporter Inhibitors
Introduction
Yunpeng Su is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of uric acid transporter inhibitors. With a total of 2 patents to his name, his work is paving the way for advancements in clinical treatments.
Latest Patents
Among his latest patents is the sodium salt of a uric acid transporter inhibitor and its crystalline form. This invention specifically focuses on a uric acid transporter (URAT1) inhibitor known as 1-((6-bromo-quinoline-4-yl)thio)cyclobutyl sodium formate. The patent details the preparation method of this compound, highlighting its good crystal form stability and chemical stability. The crystallization solvent used in this process is noted for its low toxicity and low residue, making it suitable for clinical applications.
Career Highlights
Yunpeng Su is currently associated with Jiangsu Hengrui Medicine Company Ltd., where he continues to innovate in the pharmaceutical sector. His work is instrumental in developing new therapeutic options for patients suffering from conditions related to uric acid levels.
Collaborations
He collaborates with esteemed colleagues such as Guaili Wu and Zhenjun Qiu, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Yunpeng Su's contributions to the field of uric acid transporter inhibitors exemplify the impact of innovative research in medicine. His patents not only reflect his expertise but also hold promise for future clinical applications.